A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia
This study has been completed.
Sponsor:
Centocor, Inc.
Information provided by:
Centocor, Inc.
ClinicalTrials.gov Identifier:
NCT00060502
First received: May 7, 2003
Last updated: May 16, 2011
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2006 |
| Estimated Primary Completion Date: | No date given |